Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Aekkachai Tuekprakhon(University of Birmingham), Gavin Screaton(University of Oxford), Neil G. Paterson(Diamond Light Source), Síle A. Johnson(Medawar Building for Pathogen Research), Helen M. E. Duyvesteyn(Centre for Human Genetics), Piyada Supasa(University of Oxford), Ali Amini(University of Oxford), Katie Jeffery, Raksha Das(Centre for Human Genetics), Eleanor Barnes(Oxford Health NHS Foundation Trust), Paul Klenerman(John Radcliffe Hospital), Eloise Phillips(Oxford University Hospitals NHS Trust), Helen M. Ginn(Instruct-ERIC), Aiste Dijokaite-Guraliuc(Centre for Human Genetics), Rungtiwa Nutalai(Centre for Human Genetics), Donal Skelly(John Radcliffe Hospital), Daming Zhou(Centre for Human Genetics), Alexander J. Mentzer(Centre for Human Genetics), Philip Goulder(Ragon Institute of MGH, MIT and Harvard), John Frater(University of Oxford), Anni Jämsén(Science Oxford), Muneeswaran Selvaraj(Centre for Human Genetics), Lizzie Stafford, David I. Stuart(MRC Laboratory of Molecular Biology), Jingshan Ren(Centre for Human Genetics), Alexandra Deeks(University of Oxford), Juthathip Mongkolsapaya(Centre for Human Genetics), Lucy Rothwell, Jiandong Huo(Guangzhou Experimental Station), Lisa Frending(University of Oxford), Andrew J. Pollard(University of Oxford), Sagida Bibi(University of Oxford), Nigel Temperton(Medway School of Pharmacy), Sandra Adele(Medawar Building for Pathogen Research), Elizabeth E. Fry(University of Oxford), Susanna Dunachie(Mahidol University), Tom Malone, Hermione J. Webster(University of Oxford), Bede Constantinides(University of Oxford), Derrick W. Crook(John Radcliffe Hospital), Chang Liu(Paul Scherrer Institute), Mark A. Williams(Diamond Light Source), David R. Hall(Diamond Light Source), Siobhan Gardiner(Siriraj Hospital), Teresa Lambe(Science Oxford), Christopher P. Conlon(University of Oxford), Thomas Ritter(Oxford University Hospitals NHS Trust)
Cited by 762
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k